» Articles » PMID: 31551714

Pleiotropic Roles of P2X7 in the Central Nervous System

Overview
Specialty Cell Biology
Date 2019 Sep 26
PMID 31551714
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The purinergic receptor P2X7 is expressed in neural and immune cells known to be involved in neurological diseases. Its ligand, ATP, is a signaling molecule that can act as a neurotransmitter in physiological conditions or as a danger signal when released in high amount by damaged/dying cells or activated glial cells. Thus, ATP is a danger-associated molecular pattern. Binding of ATP by P2X7 leads to the activation of different biochemical pathways, depending on the physiological or pathological environment. The aim of this review is to discuss various functions of P2X7 in the immune and central nervous systems. We present evidence that P2X7 may have a detrimental or beneficial role in the nervous system, in the context of neurological pathologies: epilepsy, Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, age-related macular degeneration and cerebral artery occlusion.

Citing Articles

P2X -receptor binding in new-onset and secondary progressive MS - a [C]SMW139 PET study.

Lehto J, Aarnio R, Tuisku J, Sucksdorff M, Koivumaki E, Nylund M EJNMMI Res. 2024; 14(1):123.

PMID: 39636350 PMC: 11621262. DOI: 10.1186/s13550-024-01186-3.


Partners in health and disease: pineal gland and purinergic signalling.

Markus R, Sousa K, Ulrich H, Ferreira Z Purinergic Signal. 2024; .

PMID: 39031242 DOI: 10.1007/s11302-024-10037-8.


Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human.

Tewari M, Michalski S, Egan T Cells. 2024; 13(2).

PMID: 38247852 PMC: 10814008. DOI: 10.3390/cells13020161.


The P2X7 Receptor, a Multifaceted Receptor in Alzheimer's Disease.

Ronning K, Dechelle-Marquet P, Che Y, Guillonneau X, Sennlaub F, Delarasse C Int J Mol Sci. 2023; 24(14).

PMID: 37511507 PMC: 10380278. DOI: 10.3390/ijms241411747.


Untangling Macropore Formation and Current Facilitation in P2X7.

Cevoli F, Arnould B, Peralta F, Grutter T Int J Mol Sci. 2023; 24(13).

PMID: 37446075 PMC: 10341454. DOI: 10.3390/ijms241310896.


References
1.
Andrei C, Dazzi C, Lotti L, Torrisi M, Chimini G, Rubartelli A . The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol Biol Cell. 1999; 10(5):1463-75. PMC: 25302. DOI: 10.1091/mbc.10.5.1463. View

2.
Baricordi O, Melchiorri L, Adinolfi E, Falzoni S, Chiozzi P, Buell G . Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J Biol Chem. 1999; 274(47):33206-8. DOI: 10.1074/jbc.274.47.33206. View

3.
Russell J, Cross A . Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease. J Neuroimmunol. 2000; 100(1-2):42-52. DOI: 10.1016/s0165-5728(99)00191-5. View

4.
Secor V, Secor W, Gutekunst C, Brown M . Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med. 2000; 191(5):813-22. PMC: 2195850. DOI: 10.1084/jem.191.5.813. View

5.
SOLLE M, Labasi J, Perregaux D, Stam E, Petrushova N, Koller B . Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem. 2000; 276(1):125-32. DOI: 10.1074/jbc.M006781200. View